Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Multi-agency investigation stops weight-loss pill scheme

This article was originally published in The Tan Sheet

Executive Summary

FDA's Office of Criminal Investigations assists an investigation leading to the arrests of Sengyang "Tom" Zhou and Qingming Hu for allegedly attempting to counterfeit and sell unapproved OTC weight-loss pills to U.S. distributors. FDA said March 25 it collaborated with U.S. Immigration and Customs Enforcement and the Postal Inspection Service to determine the origin of Superslim, 2 Day Diet and other products with the active pharmaceutical ingredient sibutramine for obesity (1"The Tan Sheet" Jan. 5, 2009). An affidavit says Zhou, a Chinese national who was arrested in Hawaii, imported the drugs and was involved with making counterfeit versions of GlaxoSmithKline's weight-loss OTC alli (2"The Tan Sheet" Jan. 25, 2010). Zhou, who operates the Web site, and Hu, who was arrested in Plano, Texas, each face three years in prison and fines up to $250,000 if convicted in the case that will be prosecuted in U.S. District Court for the District of Colorado

You may also be interested in...

GSK's Quick Warning Of Fake Alli Exemplifies Effective Crisis Management

GlaxoSmithKline's quick response to consumer complaints about counterfeit alli for sale on Internet auction sites exemplifies effective crisis management and could even boost the OTC weight-loss brand's reputation, an expert says

FDA Warns Of Possible Criminal Charges Against Weight-Loss Product Firms

FDA's enforcement action against 28 weight-loss products found to contain undeclared pharmaceutical ingredients drew applause from GlaxoSmithKline, marketer of alli, the only OTC drug approved for weight loss in the U.S

Unilever Hit With Class Action Over Mercury-Laced Pond’s Cream Originating In Mexico

According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts